Sugr Bolus Calculator News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sugr bolus calculator. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sugr Bolus Calculator Today - Breaking & Trending Today

Roche launches mySugr Pump Control within the mySugr app to simplify insulin pump therapy via smartphone


Roche launches mySugr Pump Control within the mySugr app to simplify insulin pump therapy via smartphone
News provided by
Share this article
starting in Austria, bringing more discretion and simplicity to the life of people with diabetes.
● 
in the same place where they keep their diabetes data.
● 
People with diabetes are given the possibility to share insulin pump data with their healthcare professionals for a more integrated and personalised approach to diabetes care.
- Picture is available at AP Images (http://www.apimages.com) -
BASEL, Switzerland, May 19, 2021 /PRNewswire/ Roche today announced the launch of the mySugr Pump Control, a new module within the mySugr app. The mySugr Pump Control is designed to enable people with diabetes to control an insulin pump directly via a smartphone: import its data, view its status, and remotely deliver a standard bolus. The mySugr Pump Control is an important building block within Roche s ....

United Kingdom , Prnewswire Roche , Marcel Gmuender , Adham Kassab , Yvette Petillon , Sarah Maria Richter , Soo Jin Pak , International Business Leader , Google Play , Accu Chek Insight , Sugr Pump Control , Personalised Diabetes Management , Sugr Bolus Calculator , Sugr Pump , Global Head , Roche Diabetes , Rochediabetes Care Platform , Diabetes Care , Roche Diabetes Care , Sugr Logbook , ஒன்றுபட்டது கிஂக்டம் , சூ ஜின் பக் , சர்வதேச வணிக தலைவர் , கூகிள் விளையாடு , அச்சு கன்னம் நுண்ணறிவு , தனிப்பயனாக்கப்பட்டது நீரிழிவு நோய் மேலாண்மை ,

Roche collaborates with Lilly to support people with diabetes on insulin pen therapy


Roche collaborates with Lilly to support people with diabetes on insulin pen therapy
- Roche and Lilly will integrate data from Lilly s connected insulin pen solution into the mySugr app in several countries.
- Both companies are dedicated to driving new possibilities to ease the complexity of daily decision making for people with diabetes on insulin pen therapy and their healthcare professionals.
- By collaborating with Lilly, Roche accelerates growth of its open ecosystem enabling its strategy of integrated Personalised Diabetes Management (iPDM).
BASEL, Switzerland, May 6, 2021 /PRNewswire/ Roche today announced that it has signed a collaboration agreement with Eli Lilly and Company, a global leader in diabetes care delivering innovative solutions including medicines and technologies, to work towards optimising the management of insulin pen therapy. By collaborating with Lilly, Roche follows its ambition to create an open ecosystem including its own and partn ....

Prnewswire Roche , Marie Schiller , Marcel Gmuender , Yvette Petillon , Eli Lilly , Sarah Maria Richter , Soo Jin Pak , Google Play , Novo Nordisk , Personalised Diabetes Management , Global Head , Roche Diabetes , Tempo Smart Button , Tempo Pen , Connected Care , Rochediabetes Care Platform , Diabetes Care , Roche Diabetes Care , Sugr Logbook , Sugr Bolus Calculator , மேரி ஷில்லர் , எலி லில்லி , சூ ஜின் பக் , கூகிள் விளையாடு , தனிப்பயனாக்கப்பட்டது நீரிழிவு நோய் மேலாண்மை , உலகளாவிய தலை ,

Roche collaborates with Lilly to support people with diabetes on [...] | Comunicati stampa CataniaOggi


06 maggio 2021 12:51
Fonte: Adnkronos
#salute-e-benessere
- Roche and Lilly will integrate data from Lilly s connected insulin pen solution into the mySugr app in several countries.
- Both companies are dedicated to driving new possibilities to ease the complexity of daily decision making for people with diabetes on insulin pen therapy and their healthcare professionals. 
- By collaborating with Lilly, Roche accelerates growth of its open ecosystem enabling its strategy of integrated Personalised Diabetes Management (iPDM).
BASEL, Switzerland, May 6, 2021 /PRNewswire/ Roche today announced that it has signed a collaboration agreement with Eli Lilly and Company, a global leader in diabetes care delivering innovative solutions including medicines and technologies, to work towards optimising the management of insulin pen therapy. By collaborating with Lilly, Roche follows its ambition to create an open ecosystem including its own and partner devices, solu ....

Prnewswire Roche , Marie Schiller , Marcel Gmuender , Eli Lilly , Google Play , Novo Nordisk , Personalised Diabetes Management , Global Head , Roche Diabetes , Tempo Smart Button , Tempo Pen , Connected Care , Rochediabetes Care Platform , Roche Diabetes Careroche Care , Roche Diabetes Care , Diabetes Care , Roche Diabetes Care About , Sugr Founded , Sugr Logbook , Sugr Bolus Calculator , மேரி ஷில்லர் , எலி லில்லி , கூகிள் விளையாடு , தனிப்பயனாக்கப்பட்டது நீரிழிவு நோய் மேலாண்மை , உலகளாவிய தலை , ரோச் நீரிழிவு நோய் ,

iTWire - Roche mySugr diabetes app recalled


iTWire
Friday, 09 April 2021 16:18
Roche mySugr diabetes app recalled
Featured
The mySugr Bolus Calculator from Roche Diabetes has been recalled due to a serious bug.
mySugr Bolus Calculator is intended to help users determine the insulin dose they require. It is available for iOS and Android.
But a bug means it can recommend an incorrect amount in certain circumstances.
Administering an incorrect dose of insulin can lead to serious health complications, the recall notice warns.
Users should update the app to version 3.74.1.
Roche Diabetes Care will contact affected consumers in writing.
Subscribe to ITWIRE UPDATE Newsletter here
GRAND OPENING OF THE ITWIRE SHOP ....

Stephen Withers , Sugr Bolus Calculator , Roche Diabetes , Diabetes Care , Tech Sector , Tech Youtube , Lead Generation , Tech News , Product Promos , ஸ்டீபன் வாடிவிடும் , ரோச் நீரிழிவு நோய் , நீரிழிவு நோய் பராமரிப்பு , தொழில்நுட்பம் துறை , தொழில்நுட்பம் வலைஒளி , வழி நடத்து ஜெநரேஶந் , தொழில்நுட்பம் செய்தி , ப்ராடக்ட் ப்ரோமோஸ் ,